Montrose Environmental Group Earnings Call Transcripts
Fiscal Year 2025
-
Record 2025 results with 19.3% revenue growth and 21.3% EBITDA growth, driven by strong organic performance and margin expansion. 2026 guidance targets up to $900M revenue and 15% EBITDA margin, with robust cash flow, resumed M&A, and continued demand across key markets.
-
Record Q3 and year-to-date results driven by strong organic growth, margin expansion, and robust demand across all segments. 2025 guidance was raised, with continued optimism for 2026, supported by strategic capital allocation, exit from renewables, and a planned restart of acquisitions.
-
Record Q2 results featured 35% revenue and 70% adjusted EBITDA growth, driven by strong organic performance and emergency response work. Guidance for 2025 was raised, with continued margin expansion, robust cash flow, and a simplified balance sheet supporting long-term growth.
-
Integrated environmental services are driving strong organic growth, with a focus on cross-selling to a diverse customer base and minimal federal revenue exposure. Regulatory clarity, especially around PFAS, and increased industrial activity are creating tailwinds, while operational improvements and a clean balance sheet position the company for continued margin and cash flow gains.
-
Record Q1 revenue and EBITDA were driven by strong organic growth and segment performance, leading to raised EBITDA guidance for 2025. PFAS-related services and robust private sector demand continue to support growth, while capital allocation focuses on deleveraging and stock repurchases.
-
Operations remain stable despite recent events, with no material impact from regulatory or political changes. PFAS regulations and state-level activity are driving growth, while a temporary M&A pause allows focus on deleveraging and integration. Management is highly optimistic about long-term prospects.
Fiscal Year 2024
-
Record 2024 results driven by 8.3% organic growth, strong cross-selling, and margin expansion. 2025 guidance projects continued revenue and EBITDA growth, with a focus on balance sheet optimization and steady organic performance.
-
Record Q3 results with revenue up 6.4% and EBITDA margin at 15.8%, driven by organic growth and acquisitions. Guidance for 2024 is reaffirmed, with a focus on organic growth, preferred stock redemption, and margin expansion. PFAS-related revenue and international operations remain strong.
-
Record Q2 and first-half results with 9% revenue and 10% adjusted EBITDA growth year-over-year, driven by strong organic growth and recent acquisitions. Guidance for 2024 is reiterated, with expectations for continued margin expansion and robust M&A activity.
-
The discussion highlighted that regulatory changes, including the Loper Bright ruling, are not expected to alter the business outlook or growth targets. Increased regulatory complexity and state-level authority are seen as opportunities, especially for advisory and testing services, with PFAS and methane remaining key growth drivers.